LONGWOOD FUND
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
LONGWOOD FUND
Industry:
Finance Venture Capital
Founded:
2010-01-01
Status:
Active
Contact:
(617)351-2590
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics WordPress Content Delivery Network Google Universal Analytics Font Awesome Sitelinks Search Box Yoast WordPress SEO Plugin JsDelivr
Similar Organizations
Correlation Ventures
Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.
Flybridge
Flybridge is a seed-stage venture capital firm investing with entrepreneurs to leverage the power of the community.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Photys Therapeutics | Longwood Fund investment in Series A - Photys Therapeutics | 75 M USD |
| 2022-06-23 | DEM BioPharma | Longwood Fund investment in Series A - DEM BioPharma | 70 M USD |
| 2022-06-21 | Carbon Biosciences | Longwood Fund investment in Series A - Carbon Biosciences | 38 M USD |
| 2022-04-14 | Be Biopharma | Longwood Fund investment in Series B - Be Biopharma | 130 M USD |
| 2021-10-14 | Rectify Pharmaceuticals | Longwood Fund investment in Series A - Rectify Pharmaceuticals | 100 M USD |
| 2021-10-13 | Axial Biotherapeutics | Longwood Fund investment in Series C - Axial Biotherapeutics | 37.25 M USD |
| 2021-08-18 | Immunitas Therapeutics | Longwood Fund investment in Series B - Immunitas Therapeutics | 58 M USD |
| 2021-06-23 | ImmuneID | Longwood Fund investment in Series A - ImmuneID | 50 M USD |
| 2021-05-27 | Pulmocide | Longwood Fund investment in Series C - Pulmocide | 92 M USD |
| 2021-05-18 | Interius BioTherapeutics | Longwood Fund investment in Series A - Interius BioTherapeutics | 76 M USD |